本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trevi Therapeutics Inc.

15.90
-0.0100-0.06%
盘后15.900.00000.00%19:30 EDT
成交量:201.61万
成交额:3,243.26万
市值:22.58亿
市盈率:-45.20
高:16.57
开:16.20
低:15.87
收:15.91
52周最高:20.22
52周最低:7.65
股本:1.42亿
流通股本:1.18亿
量比:1.69
换手率:1.71%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
净资产收益率:-19.66%
总资产收益率:-13.82%
市净率:7.02
市盈率(LYR):-50.11

数据加载中...

2024/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

SEC问询函

Form CORRESP - Correspondence
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/29

重要事件披露

Form 8-K - Current report
2023/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/04/14

重要事件披露

8-K - Current report
2023/04/11

关联方拟减持公告

144 - Report of proposed sale of securities